AusPAR Wegovy

Australian Public Assessment Report

AusPAR

AusPAR Wegovy [PDF, 1.39 MB]

AusPAR Wegovy [Word, 2.81 MB]

Attachment Product information for Wegovy [PDF, 1.18 MB]

Attachment Product information for Wegovy [Word, 1.28 MB]

Device/Product Name

Wegovy

Active ingredients

Semaglutide

AusPAR Date

4 September 2024

Published

5 September 2024

Submission Number

PM-2022-04980-1-5

Submission Type

Extension of indication

Decision

Approved